
location_on856, Howard Avenue, New Haven, South Central Connecticut Planning Region, Connecticut, 06519, United States
You will lead and direct the formulation and process development of patient-centered injectable drug products for Alexion's diverse portfolio. This role spans synthetic, peptide, genomic medicine, and protein-based modalities in multiple formats, including liquid, lyophilized, vial, prefilled, and cartridge-based presentations.
As a member of the Injectable Drug Product Management team, you will drive life cycle development opportunities while providing expertise in technology transfer and drug product engineering. You will manage budget and interface partners to ensure portfolio projects develop in a phase-appropriate manner. Success in this role requires deep collaboration and networking with departments within Product Development and Clinical Supplies (PDCS), as well as Alexion Operations, Clinical Development, Quality, and Regulatory organizations.
Applications for this position are accepted until May 25, 2026. The role is designated as onsite (#LI-Onsite).
Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. We welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.
Work model: On-site
856, Howard Avenue, New Haven, South Central Connecticut Planning Region, Connecticut, 06519, United States
New Haven, Connecticut
UNC Health • Chapel Hill, North Carolina
Dyne Therapeutics • Waltham, Massachusetts
Cornell Ann S. Bowers College of Computing and Information Science • City of Ithaca, New York
Knowledge of high concentration protein formulation development, aseptic processes, vial, prefilled syringe, cartridge presentations, liquid and lyophilization dosage forms.
Alexion Pharmaceuticals, Inc., based in Boston, Massachusetts, operates within the biotechnology research sector with a specialized focus on rare diseases. As part of AstraZeneca, the organization is dedicated to pioneering new possibilities for the rare disease community and driving a mission to transform the experience of living with these conditions. For over three decades, Alexion has established itself as a leader in the field, maintaining a diversified pipeline of innovative medicines designed to address significant unmet needs across various disease areas.
The company leverages an array of innovative modalities to accelerate the discovery of life-changing therapies. Its pioneering legacy is rooted in being the first to translate the complex biology of the complement system into novel treatments. Alexion continues to expand its global geographic footprint, with offices located around the world, to serve more rare disease patients internationally. This expansion reflects a commitment to broadening access to its therapies and benefiting people globally through scientific advancement and strategic growth.
Browse more roles: All Alexion Pharmaceuticals, Inc. jobs, scientific & qa jobs on Recrutus.